Translational Pain Research

Home Home Research Consortia Translational Pain Research
Fighting pain and suffering by acquiring knowledge about how pain works and driving meaningful therapeutic advances

The mission of the Gulf Coast Consortium for Translational Pain Research (GCC TPR) is to alleviate pain and suffering through innovative research that fosters the translation of basic discoveries about pain mechanisms into therapeutic advances, achieved by promoting scholarly interactions and research collaborations among scientists and clinicians within the gulf coast region.


In view of COVID_19, The Next Generation Pain Therapeutics: From Discovery to the Clinic Conference will be replaced by free virtual monthly workshops based on the planned sessions  on the third Friday of every month starting July 17. Stay tuned for more information!

Upcoming Events

There are no upcoming events at this time

Register and submit poster abstracts now for "Next Generation Pain Therapeutics: from Basic Science to the Clinic" in Houston, TX, April 13-15, 2020. #pain2020 Abstract deadline: February 26th. Great talks, posters, and updates on @US_ASP.
Please RT!

Dr. Linda Watkins shows that single dose of non-viral IL-10 gene therapy treats neuropathic pain in pet dogs suffering from pain. IL10 therapy works in real patient population! #gcctpr2019

⁦⁦@akavel⁩ Annemieke Kavelaars congratulates trainee presentation 1st place data blitz awards to Michael Lacagnina (MD Anderson) and Soha Chhaya (Drexel Univ.) at 9th Annual GCC Translational Pain Research Conference. ⁦@MJLacagnina⁩

Load More...